Cargando…
The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment
Glioblastoma (GBM) is the most aggressive malignant glioma. Therapeutic targeting of GBM is made more difficult due to its heterogeneity, resistance to treatment, and diffuse infiltration into the brain parenchyma. Better understanding of the tumor microenvironment should aid in finding more effecti...
Autores principales: | Sanders, Stephanie, Herpai, Denise M., Rodriguez, Analiz, Huang, Yue, Chou, Jeff, Hsu, Fang-Chi, Seals, Darren, Mott, Ryan, Miller, Lance D., Debinski, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468822/ https://www.ncbi.nlm.nih.gov/pubmed/34572134 http://dx.doi.org/10.3390/cells10092485 |
Ejemplares similares
-
Drug Conjugates for Targeting Eph Receptors in Glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020) -
Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020) -
Simultaneous targeting of Eph receptors in glioblastoma
por: Ferluga, Sara, et al.
Publicado: (2016) -
Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
por: Rodriguez, Analiz, et al.
Publicado: (2015) -
Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
por: Sanders, Stephanie, et al.
Publicado: (2020)